PROGLY Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for PROGLY with the United States Patent and Trademark Office. The USPTO has given the PROGLY trademark a serial number of 90263487. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 13, 2023. This trademark is owned by GRO Biosciences Inc.. The PROGLY trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others, namely, processing amino acids for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics

Scientific research, namely, research related to synthetic biology, chemical biology, protein design and development, viral resistance, and therapeutics for endocrine and immune regulation; scientific research for medical purposes, namely, developing protein-based therapeutics; developing custom proteins for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics
progly

General Information

Serial Number90263487
Word MarkPROGLY
Filing DateMonday, October 19, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, January 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Goods and ServicesBiomanufacturing for others, namely, processing amino acids for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics
Goods and ServicesScientific research, namely, research related to synthetic biology, chemical biology, protein design and development, viral resistance, and therapeutics for endocrine and immune regulation; scientific research for medical purposes, namely, developing protein-based therapeutics; developing custom proteins for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code040
First Use Anywhere DateWednesday, August 26, 2020
First Use In Commerce DateWednesday, August 26, 2020
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code042
First Use Anywhere DateWednesday, August 26, 2020
First Use In Commerce DateWednesday, August 26, 2020

Trademark Owner History

Party NameGRO Biosciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameGRO Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, January 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, January 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022SU - NON-FINAL ACTION - WRITTEN
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 3, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 26, 2022USE AMENDMENT FILED
Friday, June 3, 2022SOU EXTENSION 2 GRANTED
Thursday, May 26, 2022SOU EXTENSION 2 FILED
Friday, June 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 26, 2022TEAS EXTENSION RECEIVED
Thursday, May 26, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2021SOU EXTENSION 1 GRANTED
Tuesday, December 7, 2021SOU EXTENSION 1 FILED
Tuesday, December 7, 2021TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 18, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, March 18, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 18, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, March 18, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, March 15, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 2, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, February 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 18, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, February 18, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 18, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, February 18, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, February 12, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 22, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

progly research scientific medical namely field biology therapeutics protein applications biotherapeutics